Glenmark, Strides Pharma and Cipla recall products in US
The recall has taken place due to manufacturing issues
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Glenmark Pharma
Glenmark, Sun Pharma and two others recall products in US
As per the latest Enforcement Report by the US Food and Drug Administration (FDA), Glenmark is recalling over 6.5 lakh tubes of a…
Glenmark Pharma, USA continues to expand its OTC portfolio with acquisition of approved ANDAs from…
Glenmark’s current portfolio consists of 175 products authorised for distribution in the US marketplace and 48 ANDAs pending…
Glenmark launches Indacaterol + Mometasone FDC medicine for asthma in India
Indamet will be available in three strengths: 150 mcg/80, 160 and 320 mcg
Glenmark launches India’s first Whatsapp-based chatbot
The chatbot, "Hello Skin," will help those people who are suffering from fungal infections
Glenmark Pharma receives ANDA approval for Abiraterone Acetate tablets USP, 500 mg
The tablets are a generic version of Zytiga Tablets, 500 mg, of Janssen Biotech
Glenmark Pharma receives tentative ANDA approval for Calcipotriene and Betamethasone Dipropionate…
The drug is the generic version of Enstilar Foam, 0.005%|0.064%, of Leo Pharma AS
Glenmark launches Teneligliptin + Pioglitazone Fixed-Dose Combination drug for type-II diabetes in…
The company has launched this FDC under the brand name Zita Plus Pio, which contains Teneligliptin (20 mg) + Pioglitazone (15 mg),…
DCGI approves Glenmark’s phase-I clinical trial for its novel molecule GRC 54276
The company will initiate the trial by June 2022 to determine the safety, tolerability and preliminary anti-tumour activity of the…
Glenmark Pharma receives ANDA approval for Lacosamide tablets
The company plans to launch the product immediately